NEVVI Medicare utilization intelligence
or

← back

Provider profile

HAYES, BENJAMIN MD, PHD

Dermatology · NPI 1003963976 · SPRING HILL, TN

1
Groups
26
Codes · 2024
6,882
Disclosed services

HAYES, BENJAMIN is a Dermatology in SPRING HILL, TN, a member of 1 medical group, who billed 26 distinct codes to Medicare Part B in 2024.

Groups: SPRING HILL DERMATOLOGY PLC (MURFREESBORO, TN)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

6,882
disclosed services
26
codes billed to Medicare Part B
Prior year · CY2023 6,792 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
88305 Pathology examination of tissue using a microscope, intermediate complexity
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
17003 Destruction of precancer skin growth, 2-14 growths
96372 Injection of drug or substance under skin or into muscle
88342 Special stained specimen slides to examine tissue, initial procedure
17000 Destruction of precancer skin growth, 1 growth
11102 Biopsy of related skin growth, first growth
17110 Destruction of skin growth, 1-14 growths
96910 Therapy procedure using ultraviolet radiation with tar or petroleum jelly application
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
88312 Special stained specimen slides to identify organisms including interpretation and report
88304 Pathology examination of tissue using a microscope, moderately low complexity
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
88341 Special stained specimen slides to examine tissue, each additional procedure
11103 Biopsy of related skin growth, each additional growth
11900 Injection into skin growth, 1-7 growths
11300 Shaving of skin growth of body, arms, or legs, 0.5 cm or less
99202 New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
11301 Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm
17004 Destruction of precancer skin growth, 15 or more growths
69100 Biopsy of ear
11104 Punch biopsy, first skin growth
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
11310 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.